Penn Medicine Provider
Dermatology
Joel M. Gelfand, MD, MSCE, FAAD
5.0
(313)
Accepting new patients
Sees patients age 4 and up
Penn Dermatology Perelman
Schedule onlineCall 215-662-2737

About me

  • Director, Psoriasis and Phototherapy Treatment Center
  • Director, Center for Clinical Sciences in Dermatology
  • James J. Leyden, M.D. Endowed Professor in Clinical Investigation
  • Professor of Epidemiology in Biostatistics and Epidemiology

Education and training

  • Medical School: Harvard University
  • Residency: Mount Sinai Hospital
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

313 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
informative and helpful
June 2025
5.0
5.0
knows what he is doing
June 2025
5.0
5.0
he's a great doctor
June 2025
5.0
5.0
i feel blessed that i was able to get an appointment with dr. gelfand. i didn't know when i made the appointment that he was internationally known. he is a kind man that truly cares about his patients.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Gelfand is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Yeung H, Wan J, Van Voorhees AS, Callis Duffin K, Kreuger GG, Kalb RE, Weisman JD, Sperber BR, Brod BA, Bebo F, Schleicher SM, Shin DB, Troxel AB, and Gelfand JM. "Patient reported reasons for the discontinuation of commonly used treatments for moderate-to-severe psoriasis." , Journal of American Academy of Dermatology, 68: 2013,64-72

Mehta NN, Torigian DA, Gelfand, JM, Saboury, B, and Alavi A Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography (PET)/Computed Tomography (CT) , Journal of Visualized Experiments, 63: 2012,e3777

Azfar AS, Seminara NM, Shin DB, Troxel AB, Margolis DJ, and Gelfand JM Increased Risk of Diabetes and Likelihood of Receiving Diabetes Treatment in Patients with Psoriasis , Archives of Dermatology, 18: 2012,1 - 6

Gelfand JM, Wan J, Callis Duffin, K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Stierstorfer MB, Brod BA, Schleicher SM, Bebo BF, Troxel AB, Shin DB, Steinemann JM, Goldfarb J, Yeung H, and Van Voorhees AS Comparative Effectiveness of Commonly Used Systemic Treatments or Phototherapy for Moderate to Severe Plaque Psoriasis in the Clinical Practice Setting , Archives of Dermatology, 148(4): 2012,487-94

Langan SM, Seminara, NM, Shin, DB, Troxel A, Kimmel SE, Mehta NN, Margolis DJ, and Gelfand JM Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom , Journal of Investigative Dermatology, Advance Online Publication: 2011

Mehta N, Yu YD, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, and Gelfand JM Systemic and Vascular Inflammation in Patients with Moderate to Severe Psoriasis as measured by [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT): A Pilot Study , Archives of Dermatology, 147(9): 2011,1031-1039

Dommasch, ED, Abuabara, K, Shin, DB, Nguyen, J, Troxel, AB, and Gelfand JM. The Risk of Infection and Malignancy with Tumor Necrosis Factor Antagonists in Adult Patients with Psoriatic Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials. , Journal of the American Academy of Dermatology , 64(6): 2011,1035-1060

Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, and Gelfand JM Patients with severe psoriasis are at increased risk of cardiovascular mortality: Cohort study using General Practice Research Database , European Heart Journal , 31: 2010,1000-06

Gelfand JM, Dommasch E, Shin DB, Azfar RS, Kurd SK, Wang X, and Troxel AB The Risk of Stroke in Patients with Psoriasis , Journal of Investigative Dermatology, 129: 2009,2411-2418

Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, and Troxel AB The risk of lymphoma in patients with psoriasis , Journal of Investigative Dermatology, 126: 2006,2194-2201